Our patient Daniel (33 years old, 280 lbs, 10 years with psoriasis and PsA) saw dramatic improvements with GLP-1 therapyweight loss, reduced pain and swelling, healthier skin, and a reduced need for medications after 6 months
29,37,44,45 Oral semaglutide exposure also did not appear to be affected by upper gastrointestinal disease
ED Relevant Adverse Effects As use continues to expand, the same physiologic effects that drive the benefits of GLP-1 receptor agonists also underlie their adverse effects and ED presentations
In fact, 83.5% of the patients who developed complications at the end of the study already had DR at baseline, and the level was not described in the paper
However, between June and July 2025, switching increased sharply to 9.7%, representing more than a 16-fold rise
Its a once-a-week deal